Rare diseases
Investigational molecules
Locations
Vrchlickeho 4630/59, 586 01 Jihlava, Czechia
Nemocnice Jihlava prispevkova organizace in Jihlava, Czechia specialises in clinical trials of conditions such as Multiple sclerosis, Relapsing multiple sclerosis, Arteriosclerosis, Obesity, and other specialisations. This site conducts important research.
The medical center is at the forefront of Multiple Sclerosis research, focusing on innovative therapies to manage and treat relapsing forms of this condition. The center's work includes exploring the safety and efficacy of novel treatments like BIIB091, both as a monotherapy and in combination with other medications, to reduce Central Nervous System inflammation.
Through these studies, the center aims to enhance understanding of disease mechanisms and improve patient outcomes.
Specializing in Type 1 Diabetes Mellitus, the center is dedicated to preserving endogenous insulin secretion in newly diagnosed patients. Research efforts include evaluating the efficacy of frexalimab in combination with standard insulin therapy, aiming to maintain pancreatic function and improve long-term health outcomes.
This research is pivotal in developing strategies to delay disease progression and enhance quality of life for patients.
The center is actively engaged in addressing Obesity and related comorbidities in adolescents. By investigating the safety and effectiveness of tirzepatide, the center seeks to provide new solutions for weight management and associated health risks.
These efforts are crucial in combating the growing epidemic of obesity and its impact on youth health.
Focusing on Migraine prevention, the center conducts extensive research on the use of Dysport® for reducing migraine frequency. Studies target both chronic and episodic migraines, aiming to improve patient quality of life through effective prophylactic treatments.
By advancing migraine treatment options, the center contributes significantly to the field of neurology and patient care.
Clinical trials currently enrolling participants at this site.
CzechiaA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
CzechiaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
CzechiaStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
CzechiaStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
CzechiaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
CzechiaA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
CzechiaContinued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination
CzechiaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
CzechiaA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
CzechiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
CzechiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
CzechiaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
